Autism researchers shed light on how α2δ protein mutations affect neurodevelopmental processes microbiologystudy

A study in the journal Pharmaceuticals has uncovered how specific genetic mutations in α₂δ-1 and α₂δ-3 proteins linked to autism spectrum disorders (ASD) alter neuronal functionality. These mutations significantly reduce the proteins’ membrane expression and synaptic targeting but do not impair calcium channel activity or trans-synaptic signaling.

Conducted at Karl Landsteiner University of Health Sciences (KL Krems) within the research focus Mental Health and Neuroscience, the research provides a fresh perspective on how subtle disruptions in protein function may influence synapse formation and neuronal networks.

The results underscore the need for new experimental tools and might offer new angles for developing targeted treatments addressing the complex biology of ASD.

Autism spectrum disorder, a complex neurodevelopmental condition, affects millions worldwide and is marked by challenges in communication, social behavior, and repetitive actions.

A significant proportion of ASD cases are linked to genetic factors, with mutations in the CACNA2D1 and CACNA2D3 genes—which encode α₂δ-1 and α₂δ-3 proteins—emerging as critical players. These proteins regulate calcium channels, synapse formation, and neuronal connectivity, yet their exact role in ASD has remained elusive.

To bridge this gap, KL Krems’ Division of Physiology embarked on a comprehensive study to explore cellular pathophysiological mechanisms of mutations in these genes.

A subtle disruption

“These findings redefine how we understand the role of α₂δ proteins in brain development,” says Prof. Dr. Gerald Obermair, Head of the Division of Physiology at KL Krems. His team revealed that two specific mutations—p.R351T in α₂δ-1 and p.A275T in α₂δ-3—reduce the presence of these proteins in neuronal membranes, thereby disrupting the synaptic localization.

“What makes this discovery particularly compelling is that while the mutations don’t affect classical calcium channel functions, subtle changes may significantly affect synaptic functions,” Sabrin Haddad, M.Sc., first author of the publication and Ph.D. student in the team of Prof. Obermair, adds.

The research utilized cultured hippocampal neurons and advanced electrophysiological methods to assess how these mutations impact neuronal processes. The results showed that both p.R351T and p.A275T mutations led to a reduction in the membrane expression of α₂δ proteins, particularly in dendrites and axons, the critical sites of neuronal connectivity.

Interestingly, the p.A275T mutation in α₂δ-3 was also found to alter the protein’s glycosylation—a process critical for maintaining protein stability and function. Despite these structural disruptions, calcium channel activity and synaptic signaling were unaffected, indicating that the mutations’ impact is likely on the architecture of synapses rather than their signaling properties.

Implications for the future

The study confirmed that the overall levels of α₂δ proteins remained stable, suggesting that the mutations primarily influence their structural and surface localization roles within neurons. These findings shift the focus from traditional views of calcium channel dysfunction to exploring how protein mislocalization might affect neuronal networks.

“Our work shows that the effects of these mutations are nuanced, underscoring the need for deeper investigations into their role in neurodevelopmental disorders like autism,” Prof. Obermair states.

This research adds a critical piece to the puzzle of autism’s complex genetic underpinnings.

By revealing alternative pathways through which genetic mutations affect brain development, the study sets the stage for innovative experimental approaches as well as offering a new perspective on options for novel therapeutic options.

Provided by
Karl Landsteiner University of Health Sciences